CHF/CCM board review

Embed Size (px)

Citation preview

  • 8/10/2019 CHF/CCM board review

    1/46

    !"#$%&'(% *%+,- .+/01,%

    !"#$ &'()*+, -./.

    /*0*1*'" '2 !30+"453 65+)7 /*15+15

    8)*9(+: +"3 ;':5"

  • 8/10/2019 CHF/CCM board review

    2/46

    2/&30"&1,%

    ? (+05 "' )5>+@'"1(*=1 7' 3*14>'15

  • 8/10/2019 CHF/CCM board review

    3/46

    456%3'(%&

    !7 7(5 5"3 '2 7(*1 4'$)15, A'$ B*>> C5 +C>5 7'D

    /514)*C5 7(5 5=*35:*'>'9A +"3 =+7('=(A1*'>'9A '2

    6E

    /*+9"'15 +4$75 354':=5"1+753 6E F!/6EGD

    H>*"*4+> 5I+:

    &+7)*$)5@4 =5=@351

    J$>:'"+)A +)75)A 4+7(575)*K+@'"

    -+"+95 !/6ED

    J(+):+4'>'9*4 7)5+7:5"7

    H+)3*')5"+> 1A"3)':5

    &'"L3$)+C>5 :54(+"*4+> 1$==')7

  • 8/10/2019 CHF/CCM board review

    4/46

    2%7#/'"# "8 *%+,- .+/01,%

    ! #$% &'()*+,- .$%- ($% $%*/( '& '-0*1*23% ,4

    5*'-(*'-'-6 * 0*/7'*0 ,)(1)( *7%8)*(% (,

    *00,55,7*(% 5%(*2,3'0 /%8)'/%5%-(& *-7 ($%

    9%-,)& /%()/-:;

  • 8/10/2019 CHF/CCM board review

    5/46

    *%+,- .+/01,%9 :;% >*'" !:5)*4+"1ONPQ,QQQ "5B 4+151RA)

    SQT 35+3 B*7(*" S A)1 '2 3*+9"'1*1OSN,UVQ 35+7(1RA)

    65+>7(4+)5 8$)35"

    W.W :*>>*'" ('1=*7+>*K+@'"1RA)O:'17 2)5X$5"7 4+$15 '2

    ('1=*7+>*K+@'" *" =+@5"71 Y NS A)1

    UVT ('1=*7+>*K53 +7 >5+17 '"45 +Z5) 3*+9"'1*1

    !Z5) ('1=*7+>*K+@'", VQT W A5+) :')7+>*7A

    [QT )5L+3:*11*'" )+75 B*7(*" VQ 3+A1, SQT \ N :7(1

    ]V^.[ C*>>*'" FWL[T 7'7+> (5+>7(4+)5 4'17G!6! M7+@1@41. H*)4$>+@'" [QW[_W[SD5[L[[Q.

  • 8/10/2019 CHF/CCM board review

    6/46

    >'"0"$? "8 *%+,- .+/01,%

    `@'>'9A T

    H!/ SQ.V

    &'" H!/ a^.P

    &' 4+$15 9*05" WV.V

    H+$15 9*05" VN.a

    ?3*'=+7(*4 WU.[

    b+>0$>+) a.Q

    6c& V.U

    !>4'('> W.U

    b*)+> Q.a

    J'17=+)7$: Q.a

    !:A>'*3 Q.W

    de7(5)f P.N

    e7(5) 4+$151 7' 4'"1*35)

    g5"5@4

    H'"95"*7+> (5+)7 3*15+15

    H'4+*"5

    H(5:'7(5)+=ARhic

    H(+9+1

    6?b

    c(A)'*3

    J(5'4()':'4A7':+

    M+)4'*3

    65:'4()':+7'1*1

    j"4'"7)'>>53 7+4(A4+)3*+ F!kCG

    !3+=753 2)': i53k5>3, -+A' H>*"

  • 8/10/2019 CHF/CCM board review

    7/46

    @+-;"A;?&/"0"$? "8 *%+,- .+/01,%

    B%C D%#-,/310+, 2?&81#3'"#

    H')'"+)A /*15+15 H+)3*':A'=+7(A H+)3*+4 e05)>'+3

    D+&"3"#&-,/3'"# e)9+" 8>''3l'B H+)3*+4 i5:'35>*"9

    !Mm5>57+>

    C>''3l'B

    !i8E, &+

    )575"@'"

    nb

    /*>+7+@'"

    nb

    6A=5)7)'=(A

    MA:=7':1, E>$*3 )575"@'", /5+7(

    !))(A7(:*+1

  • 8/10/2019 CHF/CCM board review

    8/46

    EF40-50%

    EF!5

    0%

    EF"4

    0%

    E'"+)'B g, 57 +>. o!HH [QQP_ SQDPNULPP

    2/&-,/51'"# "8 >. /# @+'%#-& *"&A/-+0/F%G

    H/-; *.

    *.I@>. (&J *.,>.

    e>35)

    E5:+>5

    6c&

    Hp/

    !H!/

  • 8/10/2019 CHF/CCM board review

    9/46

    KLMK A-& H/-; !*.N >. +&&%&&=%#- 4#-+,/" @,"(/#3% OPPPIKMMO

    Q",-+0/-?N >.RSMT (&J >.UVMT WM G+?& XT (&J VT YAZMJML[

    O ?%+, K\T (&J KKT YAZMJMX[

    ]1,(/(+0 EC%, *"&A/-+0/F+'"# 8", *.

    8(+@+, 57 +>. &`o- [QQN_ VSSD[NQL^

  • 8/10/2019 CHF/CCM board review

    10/46

    !;,"#/3 *. Q+#+$%=%#- ^+&%G "# E!!_

    E*E !0+&&/73+'"#

    ]:E`> E!7 (*9( )*1m 2')

    6E C$7 B*7('$7

    17)$47$)+> (5+)7

    3*15+15 ')

    1A:=7':1 '2 6E

    ]:E`> ^M7)$47$)+> (5+)7

    3*15+15 B*7('$7

    4$))5"7 ') =)*')

    1*9"1 ')

    1A:=7':1 '2 6E

    ]:E`> !M7)$47$)+> (5+)7

    3*15+15 B*7(

    =)*') ') 4$))5"7

    1A:=7':1 '2 6E

    ]:E`> 2i52)+47')A 6E

    )5X$*)*"9

    1=54*+>*K53

    *"75)05"@'"1

    6$"7 57 +>. !"#$%&'()*[QQS_WW[DWU[SLS[.

    L c)5+7$"35)>A*"9

    )*1m 2+47')1

    L

    !H`L?

    LqL8>'4m5)

    L!i8 *2

    !H`L?

    *"7'>5)+"7

    L

    !H`L?

    L

    qLC>'4m5)

    L

    /*$)5@41 2') 1I1

    a# &%0%3-%G A-&9

    L

    M=*)'"'>+47'"5

    L

    /*9'I*"L!i8

    L6A3)+>R"*7)+751

    LHic

    L ?H/

    L J+>>*+@05 4+)5

    L ?"'7)'=51

    L

    c)+"1=>+"7

    L -HM

    L

    `I=5)*:5"7+> iI

  • 8/10/2019 CHF/CCM board review

    11/46

    !. !7 )*1m =+@5"71 B*7('$717)$47$)+> (5+)7 3*15+15

    8. M7)$47$)+> (5+)7 3*15+15

    B*7('$7 1A:=7':1

    H. M7)$47$)+> (5+)7 3*15+15 B*7(

    =)*') ') 4$))5"7 1A:=7':1

    /. i52)+47')A (5+)7 2+*>$)5

    ?. H+)3*+4 3*15+15 B*7('$7

    2$"4@'"+> >*:*7+@'"

    ??. M>*9(7 >*:*7+@'" '2 =(A1*4+>

    +4@0*7A

    ???. -+)m53 >*:*7+@'" '2 =(A1*4+>

    +4@0*7A

    ?b. ?"+C*>*7A 7' 4+))A '" =(A1*4+>

    +4@0*7A B*7('$7 3*14':2')7

    E!!_E*E !0+&&/73+'"#

  • 8/10/2019 CHF/CCM board review

    12/46

    E2*. /& + !0/#/3+0 2/+$#"&/&

    >?@A

  • 8/10/2019 CHF/CCM board review

    13/46

    ^. !: 65+)7 o [QQS_Wa^DPaa.

    @-& A,%&%#'#$ -" >c H/-; G?&A#%+

    ^

  • 8/10/2019 CHF/CCM board review

    14/46

    2/+$#"&'3 B/=/-+'"#& "8 .t B%(%0& =+? 5% %0%(+-%G %(%# /# 3"=A%#&+-%G 3;,"#/3

    *.

    t

    B/=/-%G /#3,%=%#-+0 5%#%7- "(%, 30/#/3+0 +&&%&&=%#-

    Q%+&1,%=%#- "8 ^. 65+)7 [QQV_ -4H$>>'$9( 57 +>., !op/ [QQV_ ;+"9 57

    +>., H*)4$>+@'" [QQa_ o+"$KK* 57 +>. !: o H+)3*'> [QQS_ -+*15> 57 +>., &`o- [QQ[_ ;$ 57 +>. `$) o

    65+)7 E+*>$)5 [QQV_ M(+( 57 +>. o H+)3 E+*> [QWW.

  • 8/10/2019 CHF/CCM board review

    15/46

    4-;%, :%&-& -" 2/+$#"&% E2*.

    HhiD

    4+)3*':59+>A, *"4)5+153 *"75)1@@+> :+)m*"91, p5)>5AL8

    >*"51, 5u$1*'"1

    `4('D

    nb`E, nb`//, -i, ci

    ?bH 3*+:575) Y [ 4:, 4'>>+=15 B*7( 1"*u v SQT w x HbJ

    n$"9 $>7)+1'$"3D H':571

    J$>:'"+)A +)75)A 4+7(575)*K+@'" i'$@"5 $15 "'7 )54'::5"353

    j152$> *" 45)7+*" 1*7$+@'"1

  • 8/10/2019 CHF/CCM board review

    16/46

    a& -;%,% &'00 + ,"0% 8", -;% @E

    !+-;%-%,e

    ESCAPE Investigators, JAMA 2005; 294: 1625

  • 8/10/2019 CHF/CCM board review

    17/46

    c;%# -" 3"#&/G%, @E !+-;%-%,e

    M505)5 4>*"*4+> 354':=5"1+@'" B*7( $"45)7+*"(5:'3A"+:*4 =)'k>5 CA C531*35 50+>$+@'"

    6A='75"1*'" ') B')15"*"9 )5"+> 2$"4@'" B*7(

    5:=*)*4 7(5)+=A

    J)51$:53 4+)3*'95"*4 1('4m

    !==+)5"7 *"'7)'=5 35=5"35"45 ') )52)+47')A

    1A:=7':1

    `0+>$+@'" 2') b!/ ') 7)+"1=>+"7 4+"3*3+4A

    `0+>$+@'" '2 =$>:'"+)A +)75)*+> (A=5)75"1*'"

  • 8/10/2019 CHF/CCM board review

    18/46

    :,%+-=%#- `"+0& "8 E2*.

    !33)511 =)54*=*7+@"9

    2+47')1 ?:=)'05 1I1 +"3 5"3L

    ')9+" =5)2$1*'"

    ?"*@+75 iI 7' =)505"7 3K=)'9)511*'"R:')7+>*7A

    i53$45 neM +"3 )5L

    ('1=*7+>*K+@'"

    89:*(;< "*$"(*= ;'$>)#

    '*9 >#:'>

    .)?:# @!A@

    8*$#:'B: !C

    CD(E"F: )#'& #:="E:* G'*'=: #:&'>:9 #"BHB

    1I!J/ KLM5

    @> :9%$'()*

    .)*=">%9"*'& 9F

    E'*'=:E:*> D#)=#'EB

  • 8/10/2019 CHF/CCM board review

    19/46

    @,%3/A/-+'#$ .+3-",&

    !4$75 4')'"+)A 1A"3)':51R4')'"+)A *14(5:*+

    M505)5 (A=5)75"1*'"

    !7)*+> ') 05"7)*4$>+) +))(A7(:*+1

    ?"254@'"

    J$>:'"+)A 5:C'>*

    i5"+> 2+*>$)5

    -53*4+@'"1 F5.9. &M!?/1, 175)'*31, cy/1, nL7A=5 HH81G

    &'"+3(5)5"45 F59. 1'3*$: +"3 l$*3 )517)*4@'", :53*4+@'"1G

    e7(5) 4+)3*+4 3K F+4$75 5"3'4+)3*@1, +4$75 3*1154@'", +4$75:A'=5)*4+)3*@1G

  • 8/10/2019 CHF/CCM board review

    20/46

    f+'"#+0%I !*. :;%,+A/%&BD 2?&81#3'"#

    M+>7R6[e i575"@'"

    zH+)3*+4 e$7=$7

    b+1'4'"17)*4@'"

    !Z5)>'+3J)5>'+3

    i!!MRM&M !4@0+@'"

    !H` ?"(*C*7')1!i8

    !>3'175)'"5 8>'4m5)1

    857+ C>'4m5)1

    zM+>7R0'>$:5/*$)5@41

    b5"'3*>+7')1 b+1'3*>+7')1

    ?"'7)'=51

  • 8/10/2019 CHF/CCM board review

    21/46

    4A'=/F+'"# "8 D"01=% +#G @%,81&/"#

    M7505"1'" n;. `$) o 65+)7 E+*>$)5 W^^^

    D+&"G/0+-",&

    Mbi

    E

    L >

    =/is

    Hen/

    ;!i-

    ;`c

    6*9( Mbi

    Diuretics

  • 8/10/2019 CHF/CCM board review

    22/46

    !+&%

    VW ?J"J =+# H_ #"#I/&3;%=/3 !Q@ Y>. KVT[ +G=/g%G H_ H%/$;- $+/# +#GG?&A#%+ G%&A/-% /#3,%+&/#$ ",+0 0""A G/1,%'3&J

    >h+=9 *f LV ^@ OMM_VM ff KK c%/$;- OM 05& U O =-; +$"J

    iD@ -" +#$0% "8 6+HN 30%+, 01#$&N B"1G @KN ]WN QfN G/&-%#G%G +5G"=%#N

    +#G -,+3% A%,/A;%,+0 %G%=+J

    B+5&9 *3- WMTN 3 A'$ 7)5+7 7(*1 =+@5"7{

    !.

    ?b n''= /*$)5@41

    8.

    ?b n''= /*$)5@4 | ?b b+1'3*>+7')H. ?b n''= /*$)5@4 | ?b ?"'7)'=5

  • 8/10/2019 CHF/CCM board review

    23/46

    2/1,%&/& /# E2*. n''= 3*$)5@41D ?b C'>$1 ') 4'"@"$'$1 *"2$1*'"

    E$)'15:*35, 7')15:*35, C$:57+"*35

    ?"*@+75 )+=*3>A +7 3'15 } ')+> )59*:5"

    g*05 +7 2)5X$5"7 *"75)0+>1

    N+&9)B>:#)*: '*>'=)*"B>B '#: ?:'H 9"%#:($B '*9 %B:9 E)B>&< ;)# OP

    BD'#"*= '*9 *:%#)Q)#E)*'& :R:$>B n'B5) k>>*"9 =)511$)51 >5+3 7' *:=)'053 '$74':51

    obJ v WQ $1$+>>A *:=>*51 JH; v [[ :: 69

    !*: 2') obJ v U :: 69

    ?" ib 2+*>$)5, :+A (+05 7' 15~>5 2') + 1>*9(7>A (*9(5) obJ H':=>*4+@'"1D zpR-9, :57+C'>*4 +>m+>'1*1, zgEi,

    ""5$)'('):'"+> +4@0+@'", '7'7'I*4*7A

  • 8/10/2019 CHF/CCM board review

    24/46

    24]> :,/+0

    &VQU =71 B*7( !/6E, v [a ()1 +3:*11*'"

    6?g6 01. ne; /eM` /*$)5@41

    x *:=)'05:5"7 *" 3A1="5+ \ P[ ()1

    x "57 3*$)51*1 +"3 B5*9(7 >'11 \ P[ ()1

    x =)'=')@'" BR ;iE FxH) Y Q.V :9R3nG

    &' 3*u *" 35+7(, )5L('1=*7+>*K+@'", ') `/ 0*1*71 \ NQ3

    8enjM 01. He&c?&jejM /*$)5@4 ?"2$1*'" &' 3*u5)5"45 *" +"A '$74':51

    E5>m5) 57 +>. &`o- [QWW_VNaDP^PLUQS.

    Low

    Dose

    High

    Dose

    Q12Bolus

    Continuous

    1X oral

    1X oral

    2.5X oral

    2.5X oral

  • 8/10/2019 CHF/CCM board review

    25/46

    !+&% !"#-GJ

    Eg%=A-& +- G/1,%&/& H/-; %&3+0+'#$ G"&%& "8 aD 81,"&%=/G%

    YKMM =$ aD 5/G[ 0%+G -" /#3,%+&%G ^j*"5 2') (5:'3A"+:*4 50+>$+@'"

  • 8/10/2019 CHF/CCM board review

    26/46

  • 8/10/2019 CHF/CCM board review

    27/46

    4(%,3"=/#$ l2/1,%'3 f%&/&-+#3%m

    t

    6*9( 3'15 3*$)5@41t c(*+K*35 3*$)5@41 7' +$9:5"7 >''= 5u547

    t

    -57'>+K'"5, /*$)*>

    t j>7)+k>7)+@'"

    t

    &'05> +95"71 7(+7 =)':'75 &+R6[e 5I4)5@'" +73*u5)5"7 =+)71 '2 7(5 "5=()'"D

    t

    &' C5"5k7 B*7( "51*)*@35, 7'>0+=7+", ') +35"'1*"5+"7+9'"*171 F"'7 +==)'053G

    t

    ?b 0+1'+4@05 +95"71t i5"+> 3'15 3'=+:*"5 ') 0+1'3*>+7')1

  • 8/10/2019 CHF/CCM board review

    28/46

    !Ef>]]9 j. (&J aD 2/1,%'3&

    &WUU

    M6E ') /6E

    } [ 1*9"1 '2 !/6E

    "MH) } Q.V, W[ Bm =)*')

    7' ') WQ 3 +Z5) +3:*7

    &' ?b 0+1'+4@05 :531

    MH) v V.S :9R3n

    Bart et al. NEJM 2012;367:2269-304

  • 8/10/2019 CHF/CCM board review

    29/46

    D+&"A,%&&/# f%3%A-", E#-+$"#/&-&

    H':=+)53 7' =>+45C',

    7'>0+=7+" VQ :9R3D

    !C'3A B5*9(7 \ W 3

    !3A1="5+ \ W +"3 P 3

    "15)$: 1'3*$:

    "7(*)17, 3)A :'$7(

    &' 3*u5)5"45 *" )5"+>2$"4@'"

    g(5')9(*+35 57 +>., o!-! [QQP_[^PDWVW^

    < Z SOWWN *. +G=/-N BD>. n SMTN R SL; +G=JN ]!, R WJV =$_GB

  • 8/10/2019 CHF/CCM board review

    30/46

    !+&%

    ;(+7 *1 7(5 :'17 >*m5>A 3*+9"'1*1{

    !. !4$75 :A'4+)3*+> *"2+)4@'"

    8.

    !4$75 :A'4+)3*@1

    H. !4$75 =5)*4+)3*@1 B*7( 7+:='"+35

    VS A.'. =)50*'$1>A B5>> 25:+>5 BR [ Bm1 '2 =)'9)511*05 3A="5+ "'B \

    )517. | 4(517 @9(7"511

    `I+:D 6i W[Q, 8J UQRNQ, ii VQ, M+71 ^aT i!. obJ WU 4: 6[e, C*>+75)+>

    )+>51, 1$::+@'" 9+>>$=, (5=+7':59+>A, +"3 4''> 5I7)5:*@51 BR W|

    535:+.

    M7$3*51D M*"$1 7+4( BR 3*u$15 Mc 5>50+@'", 4c"? Q.P

    `4('D nb`// WSL[QT, 9>'C+> 6p, nb`// S.S. 4:

  • 8/10/2019 CHF/CCM board review

    31/46

    2%-%,=/#+'"# "8 ^%G&/G%

    *%="G?#+=/3 @,"70%

    CONGESTION?

    ADEQUATE

    PERFUSION?

    DRY

    A B

    L C

    WET

    WARM

    COLD

  • 8/10/2019 CHF/CCM board review

    32/46

    !+1&%& "8 !+,G/"$%#/3 ];"3k

    E31-% QaJ$:= E+*>$)5

    n+)95 *"2+)4@'"

    M:+>>5) *"2+)4@'"1 B*7(=)55I*1@"9 H6E

    ?"2+)4@'" 5I75"1*'" ')

    5I=+"1*'"-54(+"*4+> 4':=>*4+@'"1

    bM/

    !4$75 -i

    E)55 ;+>> )$=7$)5

    ib *"2+)4@'"

    )$=7$)5G

    nb '$>'B 'C17)$4@'" F5.9. !M, 6H-G

    nb *"l'B 'C17)$4@'" F5.9. :AI':+, -MG!')@4 /*1154@'"

    J5)*4+)3*+> c+:='"+35

    -+11*05 =$>:'"+)A 5:C'>*1:

    `"3LM7+95 H+)3*':A'=+7(A

    J)'>'"953 H+)3*'=$>:'"+)A 8A=+11

    H+)3*+4 H'"7$1*'"

  • 8/10/2019 CHF/CCM board review

    33/46

    4A'=/F+'"# "8 D"01=% +#G @%,81&/"#

    M7505"1'" n;. `$) o 65+)7 E+*>$)5 W^^^

    D+&"G/0+-",&

    Mbi

    E

    L >

    =/is

    Hen/

    ;!i-

    ;`c

    6*9( Mbi

    Diuretics

  • 8/10/2019 CHF/CCM board review

    34/46

    aD D+&"G/0+-",& /# E2*.

    &*7)'=)$11*35D

    !)75)*+> Y 05"'$1 0+1'3*>+7')

    c*7)+75 7' Mbi UQQLW[QQ ') M8J } UQ, B(*4(505) 4':51 k)17

    H':=>*4+@'"1D (A='75"1*'", 7(*'4A+"+75 7'I*4*7A

    &*7)'9>A45)*"D

    b5"'$1 Y +)75)*+> 0+1'3*>+7')

    /)$9 '2 4('*45 2') *14(5:*+

    H':=>*4+@'"1D (A='75"1*'", (5+3+4(5, 7+4(A=(A>+I*1

    &51*)*@35D

    b5"'$1 Y +)75)*+> 0+1'3*>+7')

    J)':'751 "+7)*$)51*1 +"3 3*$)51*1

    H':=>*4+@'"1D (A='75"1*'" F9)5+75) 7(+" B*7( "*7)'9>A45)*"G

  • 8/10/2019 CHF/CCM board review

    35/46

    E]!>)*"'"5 ')3'C$7+:*"5 v S9Rm9R:*"

    M*:*>+) '$74':51 +1"*7)'9>A45)*"* No difference in WRF

    OConnor et al. NEJM 2011;365:32-43.

  • 8/10/2019 CHF/CCM board review

    36/46

    E31-% !*.I aD a#"-,"A%&

    H':=>*4+@'"1D x :A'4+)3*+> 'IA95" 35:+"3, +))(A7(:*+1,"5$)'('):'"+> +4@0+@'"

    &' :')7+>*7A C5"5k7 1"*$#:'B:9 $)ED'#:9 >) S'B)9"&'>)#B5 j15 '">A +1 C)*395 7' 35k"*@05 7(5)+=A ') 2') =+>>*+@'" *"

    :53*4+>>A )52)+47')A =+@5"71

    F/)6 MN O

    N O

    P QJ >? BRJ IRJ

    2"51-+=/#% YKIOM o$_k$_=/# p ppp pp qr rr s q

    2"A+=/#%

    OIK o$_k$_=/# t t t q q q q

    KIOM o$_k$_=/# p pp t r rr qr q

    OMIKM o$_k$_=/# ppp pp t rr qr rr q

    Q/0,/#"#% YMJOIMJXV o$_k$_=/#[ @2> W /#;/5/-", r rr ss s

  • 8/10/2019 CHF/CCM board review

    37/46

    ];",-I-%,= aD Q/0,/#"#% a# *"&A/-+0/F%G

    E2*. @+'%#-&9 4@:aQ>I!*.

    0

    2

    4

    6

    8

    10

    12

    Placebo

    Milrinone

    T@

    +'

    %#-&21,/#$*"

    &A/-+0/F+'"#

    Qa E ./5 D:_D. ^@ 2%+-;H$u5 57 +>. o!-! [QQ[_[UPDWSaWLP.

    *

    *

  • 8/10/2019 CHF/CCM board review

    38/46

    v1%&'"#

    ;(+7 7(5)+=A B'$>3 A'$ )54'::5"3{

    !.

    ?b 3*$)5@41

    8. ?b 0+1'3*>+7')1

    H. ?b *"'7)'=51

    /.

    ! | 8`. ! | H

    J7

  • 8/10/2019 CHF/CCM board review

    39/46

    !+&% !"#-GJ

    c)5+753 B*7( ?b 3'C$7+:*"5 +"3 2$)'15:*35 B*7(*:=)'05:5"7 *" (5:'3A"+:*41 +"3 H)

    !~5:=753 7' B5+" :*>)*"'"5 +"3 7)+"1*@'" 7' ')+>

    !H`L? C$7 )*1*"9 4)5+@"*"5 +"3 354)5+1*"9 $)*"5

    '$7=$7

    E5>7 7' C5 :*>)*"'"5 35=5"35"7 +"3 4'"1*35)53 2')

    +30+"453 7(5)+=*51 Fb!/R7)+"1=>+"7G

  • 8/10/2019 CHF/CCM board review

    40/46

    c;" &;"10G 5% 3"#&/G%,%G 8", +G(+#3%G

    -;%,+A/%&e

    `14+>+@"9 3*$)5@4 3'15 )5X$*)5:5"71

    J)'9)511*05 )5"+> 3A12$"4@'"

    ?"4)5+1*"9 2)5X$5"4A '2 6E ('1=*7+>*K+@'"

    ?"4)5+1*"9 C$)35" '2 05"7)*4$>+) +))(A7(:*+1

    ?"7'>5)+"45 '2 17+"3+)3 :53*4+> 7(5)+=A

    i52)+47')A 6E 1A:=7':1

    &553 2') *"'7)'=*4 1$==')7

    Y ST "'"Ll$*3 )5>+753 B5*9(7 >'11 F4+4(5I*+G

    J%#'T&: K+JB '#: *)> B'&S'=: >Q:#'D< ;)# '$%>:$'#9")=:*"$ BQ)$H

  • 8/10/2019 CHF/CCM board review

    41/46

    j&% "8 aE^@

    H'"1*35) 2')

    =+@5"71 B*7( Mc`-? B(5"

    4+)3*'95"*4 1('4m *1 "'7

    )+=*3>A )505)153 B*7(

    =(+):+4'>'9*4 7(5)+=A

    *"'7)'=5L)52)+47')A (5+)72+*>$)5 *" =+@5"71 B*7(

    4+)3*':A'=+7(A

    -53*4+>>A )52)+47')A

    05"7)*4$>+) 7+4(A4+)3*+

    -54(+"*4+> -? 4':=>*4+@'"FbM/, J+=*>>+)A :$14>5

    )$=7$)5G

    H'"7)+*"3*4+@'"1

    M*9"*k4+"7 !?

    M505)5 J!/

    !C3':*"+> +')@4 +"5$)A1:

    !')@4 /*1154@'"

  • 8/10/2019 CHF/CCM board review

    42/46

    Q%3;+#/3+0 j#0"+G/#$ 8", -;% .+/0/#$ *%+,-9

    ^%?"#G ^+00""# !"1#-%,A10&+'"#

    a=A%00+ KJVN VJM !+,G/+3E&&/&- ]?&-%=

    f%-,"$,+G% 3+##10+'"# "8 BD (/+

    8%=",+0 +,-%,?

    Q/3," Eh/+0 .0"H @1=A

    KVMMMIWMMMM ,A=

    .0"H KJV ", VJM B_=N G%A%#G/#$

    "# G%(/3%

    BD &1AA",- "#0?

    EAA,"(%G 8", 8+3/0/-+'"# "8 ;/$;I

    ,/&k @!a

  • 8/10/2019 CHF/CCM board review

    43/46

    Q%3;+#/3+0 j#0"+G/#$ 8", -;% .+/0/#$ *%+,-9

    @%,31-+#%"1& E&&/&- 2%(/3%&

    :+#G%=*%+,-9a#w"H9 KO. :,+#&&%A-+0 B%C E-,/+0

    !+##10+ (/+ 8%=",+0 (%/#

    41x0"H 9 OVIOX. .%=",+0 E,-%,?

    !%#-,/81$+0 A1=A

    Q+h XMMMILMMM ,A=

    .0"H SIV B_=

    !+# 5% 3"#7$1,%G 8", fD_^/ID

    &1AA",- H/-; G/,%3- &1,$/3+03+##10+'"#

    a#-%#G%G 8", -%=A",+,? &1AA",-

    ' ; / 8 8

  • 8/10/2019 CHF/CCM board review

    44/46

    a#&'-1-% :;%,+A/%& 8", :,%+-=%#- "8

    !;,"#/3 ]-+$% ! *.

    /*$)5@41L z 1A:=7':1

    /*9'I*"L z ('1=*7+>*K+@'"1

    b+1'3*>+7')1L x 1$)0*0+>

    !H` ?"(*C*7')1 F!i81G

    6A3)+>+K*"5L"*7)+75 *" !2)*4+" !:5)*4+"1

    857+L8>'4m5)1L x 1$)0*0+>

    /' "'7 17+)7 B(5" +4$75>A 354':=5"1+753

    !>3'175)'"5 +"7+9'"*171L x 1$)0*0+>

    `J /50*45 c(5)+=AL x 1$)0*0+>

    ?H/, Hic

  • 8/10/2019 CHF/CCM board review

    45/46

    :,%+-=%#- I 2/+&-"0/3 !*.

    c)5+7 4'"951@'"

    H'"7)'> 6c&

    c)5+7 *14(5:*+

    -+*"7+*" 1*"$1 )(A7(:

    H'"7)'> (5+)7 )+75

    0'UV%"9 #:B>#"$()*/

    9"%#:($B

    +*(PQ:*B"S:B

    0">#'>:B/ T:>'PT&)$H:#B/!!-/ @!8U!+-W

    !'#9")S:#B")* "; +XT

    -:>'PT&)$H:#B/ !!-/9"=)Y"*/ +K *)9'&

    'T&'()*

  • 8/10/2019 CHF/CCM board review

    46/46

    ]1==+,?

    6E *1 + 4>*"*4+> 3*+9"'1*1, C$7 8&J :+A C5 $152$> B(5" 7(5)5 *1 3*+9"'1@4

    $"45)7+*"7A

    c)5+7:5"7 '2 6E 1('$>3 C5 7+)95753 +7 '=@:*K+@'" '2 0'>$:5 17+7$1 B*7(

    :+*"75"+"45 '2 +35X$+75 5"3L')9+" =5)2$1*'"

    J+@5"71 1('$>3 C5 3*$)5153 7' obJ v WQ 4: 6[e B(5" ='11*C>5 +"3

    0+1'3*>+7')1 1('$>3 C5 $153 *" =)525)5"45 7' *"'7)'=51

    i'$@"5 *"0+1*05 (5:'3A"+:*4 :'"*7')*"9 'u5)1 "' +30+"7+95 '05)

    C531*35 4>*"*4+> +11511:5"7

    ?"*@+75 >*251+0*"9 7(5)+=*51 =)*') 7' ('1=*7+> 3*14(+)95 +"3 4'')3*"+75

    >'"9*7$3*"+> 2'>>'BL$=

    J+@5"71 B*7( )52)+47')AR)54$))5"7 1A:=7':1 7(+7 +)5 )51*17+"7 7'17+"3+)3 7(5)+=A 1('$>3 C5 )525))53 2') 4'"1*35)+@'" '2 +30+"453

    7(5)+=*51